ARDX today
$3.12-$0.01 (-0.32%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourBearish
15 minSymmetric Triangle
5 minSymmetric Triangle
Daily trend turns up above $3.41
Key levels
Resistance$3.63
Resistance$3.41
Support$3.06
Support$2.80
Latest news & SEC filings
EarningsArdelyx Posts Q3 2026 Results
ProductArdelyx finishes patient enrollment in Phase 3 ACCEL trial of IBSRELA for chronic idiopathic constipation
EarningsArdelyx holds Q3 2026 earnings call
EarningsArdelyx reports Q3 sales of $125.5 million, below $128.42 million estimate
All ARDX news →About Ardelyx
Ardelyx discovers and sells prescription drugs built on tenapanor, an oral compound it developed that acts on a gut transporter called NHE3. Two of its medicines are cleared for sale in the United States: one is for grown patients suffering from irritable bowel syndrome accompanied by constipation, and the other lowers phosphorus levels in kidney disease patients receiving dialysis. The company is also testing tenapanor for a second constipation-related condition and developing a follow-on NHE3 compound, while licensing its drug to partners in Canada, Japan and China.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
ARDELYX, INC. (ARDX)
What Is the Price Target for ARDX?
SEPT Low Target
$9.00
SEPT Mid Target
$11.00
SEPT High Target
$15.00
Analyst Consensus
$11.00
Is ARDX a Buy or Sell Right Now?
Thesis
- •Revenue growing 22.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ARDX.
Start Free Trial →Is ARDX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$8.63
15
Moat Score
NONE
2/9
Piotroski Score
-0.1
Altman Z-Score
What Is Smart Money Doing with ARDX?
Insider Signal
SELLING
0 buys / 19 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hohenleitner Susan | officer | Sale | 1,455 | $9K | May 21, 2026 |
| Brady James Parker | officer | Sale | 1,846 | $12K | May 21, 2026 |
| Reilly Joseph James | officer | Sale | 2,683 | $17K | May 21, 2026 |
| Reilly Joseph James | officer | Sale | 1,036 | $6K | May 21, 2026 |
| Foster Eric Duane | officer | Sale | 3,166 | $20K | May 21, 2026 |
| Foster Eric Duane | officer | Sale | 2,427 | $15K | May 21, 2026 |
| Foster Eric Duane | officer | Sale | 2,405 | $15K | May 21, 2026 |
| Kelliher Mike | officer | Sale | 2,900 | $18K | May 21, 2026 |
| Kelliher Mike | officer | Sale | 1,870 | $12K | May 21, 2026 |
| Kelliher Mike | officer | Sale | 2,478 | $16K | May 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ARDX Growth Story
Revenue YoY
22.1%
3yr Revenue CAGR
98.4%
EPS Growth YoY
-52.94%
FCF Growth YoY
4.0%
Revenue Trend
STRONG
Dark Pool Trades for ARDX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ARDX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:09:20 | $3.11 | 1,500 | $$5K | BUY |
| 21:01:53 | $3.12 | 3,505 | $$11K | BUY |
| 21:01:53 | $3.12 | 1,495 | $$5K | BUY |
| 21:01:08 | $3.12 | 1,298 | $$4K | BUY |
| 21:00:58 | $3.12 | 2,098 | $$7K | BUY |
5 dark pool trades shown · $$31K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ARDX
PREVIEWSEPT Investing provides real-time options flow tracking for ARDX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $3.5 | Dec 18 | 36 | $$20 | 1 | SWEEP |
| CALL | $3.5 | Dec 18 | 36 | $$20 | 1 | SWEEP |
| CALL | $3.5 | Dec 18 | 36 | $$20 | 1 | SWEEP |
| CALL | $4 | Jan 15 | 64 | $$50 | 5 | SWEEP |
| CALL | $4 | Jan 15 | 64 | $$50 | 5 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ARDELYX, INC. (ARDX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ARDX — frequently asked questions
What is ARDX stock price today?
ARDELYX, INC. (ARDX) is at $3.12, down 0.32% (-$0.01) at the Nov 12, 2026 close.
Why is ARDX stock moving today?
Latest ARDX news — Nov 4, 2026: Ardelyx Posts Q3 2026 Results · Nov 3, 2026: Ardelyx finishes patient enrollment in Phase 3 ACCEL trial of IBSRELA for chronic idiopathic constipation
What is the ARDX price target?
The average analyst price target for ARDX is $11.00, ranging from $9 to $15, based on 5 analysts.
What do analysts rate ARDX?
Analyst ratings for ARDX: 0 Buy, 7 Hold, 0 Sell — consensus Hold.
Did ARDX beat earnings?
ARDX last reported on Aug 6, 2026: EPS -$0.07 vs -$0.07 expected — a miss of 6.9%.
Does ARDX pay a dividend?
ARDX does not currently pay a dividend.
How much debt does ARDX have?
ARDELYX, INC. reported $252M of debt and $97M of cash (Jun 30, 2026).
What are ARDX support and resistance levels?
Support: $3.06, $2.80. Resistance: $3.41, $3.63, $3.83.
What are insiders doing with ARDX?
Insider activity: SELLING, 0 buys and 19 sells in the last 90 days.
What is the latest news on ARDX?
Nov 4, 2026: Ardelyx Posts Q3 2026 Results · Nov 3, 2026: Ardelyx finishes patient enrollment in Phase 3 ACCEL trial of IBSRELA for chronic idiopathic constipation · Nov 3, 2026: Ardelyx holds Q3 2026 earnings call